PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252678
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252678
Cell Dissociation Market size was valued at USD 580.7 Million in 2022, expanding at a CAGR of 20.3% from 2023 to 2030.
The technique of cell dissociation involves the use of a proteolytic enzyme that facilitates the breakdown of proteins, thus enabling adhered cells to be separated from the surface of the cell culture vessel. This breakdown process is crucial in order to utilize the cells for further experimentation. To effectively isolate the cells, cell dissociation reagents that possess proteolytic and collagenolytic properties are utilized to detach the cell lines and tissues from the plastic and glass surfaces of the container, thereby enhancing cell viability and isolation efficiency. The selection of an appropriate cell dissociation agent is based on the type of tissue or cell being utilized and the age of the cells in the culture medium.
The global industry for cell culture products is experiencing rapid growth, with a broad range of options available to aid researchers, and pharmaceutical players in their efforts to study, manipulate, and utilize cells. The COVID-19 pandemic has further fueled the demand for these products, as cell culture technologies have played a critical role in developing therapeutic and diagnostic options for the disease. For example, these techniques have provided essential tools for the manufacture of viral particles required for vaccine development, thereby expanding growth opportunities in this market. The increasing focus on the development of cell-based therapeutics is a significant factor driving the industry's growth. A surge in clinical trials, FDA approvals, and strategic initiatives by key players is further boosting market expansion. For instance, in December 2022, Sanofi and Innate Pharma SA announced an expansion of their collaboration with Sanofi to develop natural killer cell therapeutics for the treatment of oncological conditions.
Additionally, researchers are concentrating on developing advanced technologies to meet the increasing demand for cell culture products. For example, a team of researchers from Brown University is working on an affordable, easy-to-use, and portable device that can effectively separate tissues into viable single cells using electrical means. This approach is anticipated to be beneficial for both basic scientific research and clinical diagnostics. The research team has also joined forces with PerkinElmer to transform this technology into a commercial product. Additionally, the researchers are exploring other cutting-edge physical mechanisms for cell dissociation.
The Global Cell Dissociation Market is segmented on the basis of Product, Type, Application, and Region.
In 2022, the enzymatic dissociation segment held the largest share of the global industry and contributed to over 48.90% of the overall revenue. The global market is further classified into non-enzymatic dissociation and instruments & accessories based on the product. Enzymatic dissociation utilizes enzymes to digest tissue pieces, thereby releasing the cells from the tissue. Various types of enzymes are employed in the dissociation process, and they can also be used in combination. Enzymatic dissociation methods provide an efficient and effective means of isolating mononuclear cells from the spinal cord and brain. The non-enzymatic segment is expected to register the highest CAGR between 2023 and 2030.
The global industry has been further segmented into tissue dissociation and cell detachment based on type. In 2022, the tissue dissociation type segment emerged as the dominant category, contributing to 57.5% of the overall revenue. This segment is expected to continue its dominant position in the global market with a steady growth rate. The increasing focus of biopharmaceutical and pharmaceutical companies on the development of monoclonal antibodies and customized treatments are expected to fuel the growth of this segment.
The industry has been further classified into pharmaceutical and biotechnology companies and research & academic institutes based on application. The pharmaceutical and biotechnology companies' category dominated the industry in 2022, contributing to over 70.50% of the overall revenue. This segment is expected to maintain its leading position in the global market during the forecast period, with the fastest growth rate among all the segments.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America emerged as the dominant region in the global industry in 2022, contributing to over 38.10% of the overall revenue. The high share of the region can be attributed to the government's rise in investment initiatives, increasing incidence of chronic diseases like cancer, and the presence of high-quality infrastructure for clinical & laboratory research in the region. For instance, the United States recorded approximately 2,281,658 new cancer cases and nearly 612,390 deaths, according to the Globocan report in 2020. The rising prevalence of chronic and infectious diseases, along with the increasing focus on cell-based therapeutics, is further expanding the growth prospects of the market in this region.
The Asia Pacific region is expected to witness the fastest growth rate during the forecast period due to the increasing demand for novel therapeutics and the rising focus on R&D investments by governments. The rapid infrastructural development in the region is also a key factor driving the market growth. Additionally, several regional companies are receiving funding to develop treatments for various chronic diseases, such as cancer, which is further fueling the growth of the industry. For example, Immuneel Therapeutics received a budget of USD 15 million in June 2022, to develop affordable cell and gene therapy for cancer patients in India. This funding is expected to boost the development of innovative cell culture techniques and increase the adoption of cell culture products in the Asia Pacific region.
The market's leading companies are implementing a range of strategies such as innovative product launches, partnerships, collaborations, mergers and acquisitions, and geographical expansions to enhance their market presence. One notable example is S2 Genomics, which launched the Singulator 100 System in February 2020. This automated system is designed to convert solid tissue samples into suspensions of nuclei or single cells, allowing for a wide range of genomic analyses and single-cell biology. With high yields and the ability to process small samples, the Singulator 100 System standardizes the dissociation method of solid tissues, making it easier for investigators to consistently prepare high-quality nuclei or cells with minimal variability. This innovative technology is set to revolutionize the field of genomics and contribute to advances in single-cell biology.
This proposed research study on Cell Dissociation Market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cell Dissociation Market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cell Dissociation Market
Impact of COVID-19 on Cell Dissociation Market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cell Dissociation Market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Cell Dissociation Market, we have also included competitive landscape and key innovator analysis for the Cell Dissociation Market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Cell Dissociation Market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Cell Dissociation Market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
GLOBAL CELL DISSOCIATION MARKET KEY PLAYERS
Merck KGaA
Thermo Fisher Scientific
Danaher Corp.
STEMCELL Technologies
Sartorius AG
BD
Miltenyi Biotec
PAN-Biotech
HiMedia Laboratories
F. Hoffmann-La Roche Ltd.
S2 Genomics, Inc.
GLOBAL CELL DISSOCIATION MARKET, BY PRODUCT
Enzymatic Dissociation
Non-enzymatic dissociation
Instruments & Accessories
GLOBAL CELL DISSOCIATION MARKET, BY TYPE
Tissue Dissociation
Cell Detachment
GLOBAL CELL DISSOCIATION MARKET, BY APPLICATION
Pharmaceutical And Biotechnology Companies
Research & Academic Institutes
GLOBAL CELL DISSOCIATION MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA